Siemens Healthineers said that it will invest an additional one billion yuan (US$141.8mil or RM647mil) to set up a new research and production site in Shenzhen, Guangdong province, marking its second such facility in the southern metropolis. — China Daily
SHENZHEN: Siemens Healthineers, a German healthcare equipment provider, is betting big on China’s innovation and manufacturing capacity.
On Monday, it announced it will invest an additional one billion yuan (US$141.8mil or RM647mil) to set up a new research and production site in Shenzhen, Guangdong province, marking its second such facility in the southern metropolis.
“China is of elementary importance for Siemens Healthineers. Through its technology savvy and openness to partnerships and innovation, China is already, and will continue to be, a strategic innovation driver for us locally as well as globally,” said chief executive officer Bernd Montag.
He made the remarks in Shenzhen during a signing ceremony for strategic collaboration between the company’s Shenzhen base called Siemens Shenzhen Magnetic Resonance Ltd and the Nanshan district of Shenzhen, to build the site.
Noting that China is an “important and dynamic” market, Montag said the country is also becoming an increasingly important source of innovation and creativity.
Wang Hao, president of Siemens Healthineers Greater China, said the company’s latest investments in Shenzhen demonstrate its determination and confidence in the Chinese market.
The company will further enhance local production and research and development capabilities in China to cultivate a comprehensive local innovation ecosystem, he said. — China Daily/ANN
